Manufacture

Demand for cell and gene therapies is increasing, but are current manufacturing approaches up to the task?

Though key hurdles remain, there is huge potential for mRNA-based therapeutics to tackle areas of unmet need.

Walking through the mRNA manufacturing process – and its many challenges.

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

BASF has put substantial effort into reducing carbon emissions. A key aspect of their strategy lies in extracting and acting upon the right data.

Widely-used antimalarial drugs are losing efficacy. What are researchers doing to prevent that?

A growing number of deaths linked to pediatric medicines prompts the WHO to investigate “unacceptable” levels of APIs.

How critical anti-cancer drugs can be sustainably developed from genetically engineered baker’s yeast.

Could nucleic acid medicines be the solution to the complex problems associated with advanced therapy manufacture?

The remarkable story of gene therapy drug development during the 1990s and early 2000s.